Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Nuclear Medicine|May 11, 2022
Outcome of 177 Lu-PSMA Radionuclide Treatment in Advanced Prostate Cancer and Its Association With Clinical Parameters : A Single-Center ExperienceDuygu Has Simsek, Serkan Kuyumcu, Seyfullah Karadogan, et al.
Clinical Nuclear Medicine|October 1, 2021
225Ac-Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: A Single-Center ExperienceYasemin Sanli, Serkan Kuyumcu, Duygu Has Simsek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 26, 2026
Evaluating chronic bone and soft tissue infections with [68Ga]Ga-Pentixafor PET/CT: a head-to-head comparison with scintigraphyDilara Denizmen Zorba, Duygu Has Simsek, Yasemin Sanli, et al.
Clinical Nuclear Medicine|April 22, 2021
Safety of Fibroblast Activation Protein-Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04Serkan Kuyumcu, Bilal Kovan, Yasemin Sanli, et al.
Clinical Nuclear Medicine|July 14, 2022
SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast CancerDuygu Has Simsek, Selman Emiroglu, Ravza Yilmaz, et al.
Annals of Nuclear Medicine|March 30, 2021
Can PSMA-based tumor burden predict response to docetaxel treatment in metastatic castration-resistant prostate cancer?Duygu Has Simsek, Serkan Kuyumcu, Seyfullah Karadogan, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 24, 2024
Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90Y Selective Internal Radiation Therapy PlanningBilal Kovan, Dilara Denizmen, Caner Civan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 10, 2023
The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumorsDuygu Has Simsek, Yunus Guzel, Dilara Denizmen, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 14, 2025
The Schrödinger's Cat Paradox: Can MAMMI PET with 68Ga-FAPI Determine Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Omitting Surgery?Melis Oflas, Duygu Has Simsek, Ravza Yilmaz, et al.
Annals of Nuclear Medicine|June 29, 2021
Prognostic significance of 68Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to 18F-FDG PET/CT and laboratory resultsSerkan Kuyumcu, Emine Goknur Isik, Tarik Onur Tiryaki, et al.
Pageof 5